Webinar Recorded on September 16, 2025                        Pricing: Free for Members and Non-Members

Please note that this session is not accredited for continuing pharmacy education credit.

Program Description

Advance understanding of the importance of frequent risk assessment and monitoring of patients with PAH and how near-normalization of the right heart is associated with improved risk status. Participants will learn about the significant role that risk stratification plays in informing providers' treatment decisions, the significance of right heart and hemodynamic considerations in conjunction with risk assessment, and the importance of timely adjustment of therapies in the treatment of PAH.

This webinar is sponsored, developed, and presented by the sponsor. The content of this Science & Innovation Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP.

Sponsored by:

For individuals from the media/press interested in attending, please email media@amcp.org.